Lung cancer is the most common and deadly cancers worldwide. Individuals with a habit of regular smoking have the highest chances of lung cancer. Lung cancer risk also increases with the length of time and number of cigarettes individual smoke. If the individual stop smoking, even after smoking for various years, it can significantly lessen the chances of developing lung cancer.
As a matter of fact, lung cancer also can occur in individuals who have never smoked in their entire life. According to a research, lung cancer affects approximately 2.1 million population every year and causes around 1.7 million deaths, making it the leading cause of cancer deaths in males as well as females.
However, from the last a few years immunotherapy treatment has brought a new hope to many patients.
Immunotherapy is a type of cancer treatment that strengthens the immune system to fight against several types of cancer. Compared to other cancer therapies, like radiation therapy and chemotherapy, immunotherapy is both an accessible and affordable option. However, immunotherapy is yet very less common than surgery, chemotherapy, or radiation therapy.
Immunotherapy is often used to treat people with stage 3 or stage 4 lung cancer. It is considered as a successful treatment option for both small cell and non-small cell lung cancer.
In general, cancer cells can hide from the immune system or block its response. Immunotherapy works by removing these blocks or boosting the immune system’s ability to find and destroy cancer.
It includes various types of Immunotherapy treatments. Some of them are:
Individuals can get immunotherapy at:
Lung cancer is mainly divided into two types. Let’s discuss them briefly.
Both Small cell lung cancer and Non-small cell lung cancer can be treated and managed with immunotherapy; thus the approach and effectiveness can differ.
In recent years, checkpoint inhibitors like nivolumab, pembrolizumab, and atezolizumab have become standard treatments for advanced NSCLC.
Checkpoint inhibitors target proteins like PD-1, PD-L1, and CTLA-4. These proteins normally help keep the immune system from attacking healthy cells. But cancer cells use them to avoid being attacked. By blocking these proteins, checkpoint inhibitors allow immune cells to attack cancer more effectively.
SCLC is more aggressive and spreads quickly. For many years, chemotherapy was the only option. But in 2019, the FDA approved atezolizumab (a checkpoint inhibitor) with chemotherapy as a first-line treatment for extensive-stage SCLC 2.
Cost of Lung Cancer Immunotherapy in India
Let us review the table to determine the approximate price of different types of immunotherapy.
Types of Immunotherapy Treatment | Cost of Treatment (INR) |
Checkpoint Inhibitors | Rs.1.5 lakhs – Rs.4 lakhs per dose |
Monoclonal Antibodies | Rs.1.25 lakhs – Rs.3.5 lakhs per cycle |
CAR T-Cell Therapy | Rs.41 lakhs –Rs.71 lakhs ( approx.) |
Cancer Vaccines | Rs.1 lakh – Rs.2 lakhs (experimental) |
Cytokine Therapy | Rs.50,000 – Rs.2 lakhs (limited use) |
TIL Therapy | Rs.20 lakhs – Rs.40 lakhs (in trials) |
Cost of Immunotherapy in the Indian Market
City | Cost per Session (₹) | Full Treatment (₹) |
Delhi | Rs. 50,000 - Rs. 1,20,000 | Rs. 3-10 lakhs |
Mumbai | Rs. 55,000 - Rs. 1,50,000 | Rs. 4-12 lakhs |
Bangalore | Rs. 45,000 - Rs. 1,10,000 | Rs. 3-9 lakhs |
Chennai | Rs. 40,000 - Rs. 1,00,000 | Rs. 2.5-8 lakhs |
Hyderabad | Rs. 42,000 - Rs. 95,000 | Rs. 2.5-7.5 lakhs |
Kolkata | Rs. 38,000 - Rs. 90,000 | Rs. 2-7 lakhs |
Remember, all lung cancer patients are not eligible for immunotherapy. Doctors look at factors like:
The common side effects of Immunotherapy for lung cancer include:
Immunotherapy has changed the way lung cancer is treated. It has given a new hope to the patients who previously had few options. While it is not a cure for everyone, but it has helped many people live a longer and happier lives.